New Search

Your search found 36 records, sorted by year and then date of acquisition.

1. Protocol Information: CTN-0001 - Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification doc type
  CTN Dissemination Library protocol page
 
2. Racial/Ethnic Differences in the Rates and Correlates of HIV Risk Behaviors Among Drug Abusers. doc type
  Brooks, Audrey J. ; Lokhnygina, Yuliya ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Calsyn, Donald A. ; Greenfield, Shelly F.
 American Journal on Addictions 2013;22(2):136-147. [doi: 10.1111/j.1521-0391.2013.00303.x].
 
3. Depressive Symptoms, Substance Use and HIV-Related High Risk Behaviors among Opioid-Dependent Individuals: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Ling, Walter
 Substance Use & Misuse 2011;46(14):1716-1725. [doi: 10.3109/10826084.2011.611960].
 
4. Barriers to Implementing MAT. doc type
  Winstanley, Erin L.
 Presented at the South Dakota Association of Addiction & Prevention Specialists conference, Mitchell, SD, September 28-30, 2011.
 
5. Assessing Drug Use during Follow-Up: Direct Comparison of Candidate Outcome Definitions in Pooled Analyses of Addiction Treatment Studies. doc type
  Korte, Jeffrey E. ; Magruder, Kathryn M. ; Chiuzan, Codruta C. ; Logan, Sarah L. ; Killeen, Therese ; Bandyopadhyay, Dipankar ; Brady, Kathleen T.
 American Journal of Drug and Alcohol Abuse 2011;37(5):358-366. [doi: 10.3109/00952990.2011.602997].
 
6. Substance Use Treatment with Ethnic Minorities: Lessons Learned in the Clinical Trials Network of the National Institute on Drug Abuse. doc type
  Burlew, Ann Kathleen ; Rosa, Carmen L. ; Brooks, Audrey J. ; Weekes, Jerren C. ; Forcehimes, Alyssa A.
 Symposium presented at the American Psychological Association (APA) convention, Washington, DC, August 4-7, 2011.
 
7. Co-Occurring Amphetamine Use and Associated Medical and Psychiatric Comorbidity Among Opioid-Dependent Adults: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Woody, George E. ; Ling, Walter
 Substance Abuse and Rehabilitation 2011;2:133-144. [doi: 10.2147/SAR.S20895].
 
8. Use of Item Response Theory and Latent Class Analysis to Link Poly-Substance Use Disorders with Addiction Severity, HIV Risk, and Quality of Life Among Opioid-Dependent Patients in the Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Yang, Chongming ; Pan, Jeng-Jong ; Reeve, Bruce B. ; Woody, George E.
 Drug and Alcohol Dependence 2011;118(2-3):186-193. [doi: 10.1016/j.drugalcdep.2011.03.018].
 
9. The National Drug Abuse Treatment Clinical Trials Network: Forging a Partnership between Research Knowledge and Community Practice. doc type
  Tai, Betty ; Sparenborg, Steven ; Liu, David S. ; Straus, Michele M.
 Substance Abuse and Rehabilitation 2011;2:21-28. [doi: 10.2147/SAR.S16756].
 
10. Clinical Correlates of Health-Related Quality of Life Among Opioid-Dependent Patients. doc type
  Heslin, Kevin C. ; Stein, Judith A. ; Heinzerling, Keith G. ; Pan, Deyu ; Magladry, Christine ; Hays, Ron D.
 Quality of Life Research 2011;20(8):1205-1213. [doi: 10.1007/s11136-011-9858-y].
 
11. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
12. Gender and Racial/Ethnic Differences in Addiction Severity, HIV Risk, and Quality of Life among Adults in Opioid Detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Shostak, Jack ; Woody, George E.
 Substance Abuse and Rehabilitation 2010;1:13-22. [doi: 10.2147/SAR.S15151].
 
13. Predictors of Study Retention in Drug Abuse Treatment Trials. doc type
  Korte, Jeffrey E. ; Magruder, Kathryn M. ; Sonne, Susan C. ; Sampson, Royce ; Brady, Kathleen T.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
14. Ten Years of Pharmacotherapy Trials in the CTN: An Overview. doc type
  Brady, Kathleen T.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
15. The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment. doc type
  Tai, Betty ; Straus, Michele M. ; Liu, David S. ; Sparenborg, Steven ; Jackson, T. Ronald ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13. [doi: 10.1016/j.jsat.2010.01.011].
 
16. Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead? doc type
  Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].
 
17. Partnerships and Pathways of Dissemination: The National Institute on Drug Abuse - Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. doc type
  Martino, Steve ; Brigham, Gregory S. ; Higgins, Christine ; Gallon, Steve ; Freese, Thomas E. ; Albright, Lonnetta M. ; Hulsey, Eric G. ; Krom, Laurie ; Storti, Susan A. ; Perl, Harold I. ; Nugent, Cathrine D. ; Pintello, Denise ; Condon, Timothy P.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S31-S43. [doi: 10.1016/j.jsat.2009.12.013].
 
18. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
19. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
20. Multisite Effectiveness Trials of Treatments for Substance Abuse and Co-Occurring Problems: Have We Chosen the Best Designs? doc type
  Nunes, Edward V. ; Ball, Samuel A. ; Booth, Robert E. ; Brigham, Gregory S. ; Calsyn, Donald A. ; Carroll, Kathleen M. ; Feaster, Daniel J. ; Hien, Denise A. ; Hubbard, Robert L. ; Ling, Walter ; Petry, Nancy M. ; Rotrosen, John ; Selzer, Jeffrey A. ; Stitzer, Maxine L. ; Tross, Susan ; Wakim, Paul G. ; Winhusen, Theresa M. ; Woody, George E.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S97-S112. [doi: 10.1016/j.jsat.2010.01.012].
 
21. Retention of Under-Represented Minorities in Drug Abuse Treatment Studies. doc type
  Magruder, Kathryn M. ; Ouyang, Bichun ; Miller, Scott ; Tilley, Barbara C.
 Clinical Trials 2009;6(3):252-260. [doi: 10.1177/1740774509105224].
 
22. Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multicenter Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. doc type
  Ziedonis, Douglas M. ; Amass, Leslie ; Steinberg, Marc ; Woody, George E. ; Krejci, Jonathan ; Annon, Jeffrey J. ; Cohen, Allan J. ; Waite-O'Brien, Nancy ; Stein, Susan M. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Maslansky, Robert ; Winhusen, Theresa M. ; Babcock, Dean ; Brigham, Gregory S. ; Muir, Joan A. ; Orr, Deborah ; Buchan, Betty J. ; Horton, Terry ; Ling, Walter
 Drug and Alcohol Dependence 2009;99(1-3):28-36. [doi: 10.1016/j.drugalcdep.2008.06.016].
 
23. Understanding and Utilizing Buprenorphine in the Treatment and Short Term Detox of Opioid Addiction. doc type
  Freese, Thomas E. ; Detmer, Mary Ann ; Brigham, Gregory S.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
24. Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. doc type
  Scott, Alena I. ; Levy, Janet A. ; Murphy, Susan A.
 State College, PA : The Methodology Center, Pennsylvania State University, Technical Report #07-82, 2007, 30p..
 
25. The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings (Blending Team Product). doc type
  National Institute on Drug Abuse (NIDA) ; Substance Abuse and Mental Health Services Administration (SAMHSA) ; Addiction Technology Transfer Center (ATTC) National Office
 Produced by the NIDA/SAMHSA-ATTC Blending Initiative, 2007.
 
26. Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M.
 American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418].
 
27. The Value of Ongoing Evaluation in Adopting Buprenorphine-Naloxone Short-Term Taper. doc type
  Brigham, Gregory S.
 Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
 
28. Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. doc type
  Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron
 Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021].
 
29. Using Buprenorphine to Facilitate Entry into Residential Therapeutic Community Rehabilitation. doc type
  Collins, Eric D. ; Horton, Terry ; Reinke, Katherine ; Amass, Leslie ; Nunes, Edward V.
 Journal of Substance Abuse Treatment 2007;32(2):167-175. [doi: 10.1016/j.jsat.2006.03.018].
 
30. Using Buprenorphine Short-Term Taper to Facilitate Early Treatment Engagement. doc type
  Brigham, Gregory S. ; Amass, Leslie ; Winhusen, Theresa M. ; Harrer, Judith M. ; Pelt, Alvin
 Journal of Substance Abuse Treatment 2007;32(4):349-356. [doi: 10.1016/j.jsat.2006.09.006].
 
31. Short Term Opioid Withdrawal Using Buprenorphine (Blending Team Product). doc type
  Freese, Thomas E. ; Brigham, Gregory S. ; Finnerty, Beth ; Gresham-Morrison, Kay ; Harrer, Judith M. ; McCarty, Dennis ; Storti, Susan A.
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2006.
 
32. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 
33. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.
 
34. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. doc type
  Amass, Leslie ; Ling, Walter ; Freese, Thomas E. ; Reiber, Chris ; Annon, Jeffrey J. ; Cohen, Allan J. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Clark, Cynthia ; Ziedonis, Douglas M. ; Krejci, Jonathan ; Stine, Susan M. ; Winhusen, Theresa M. ; Brigham, Gregory S. ; Babcock, Dean ; Muir, Joan A. ; Buchan, Betty J. ; Horton, Terry
 American Journal on Addictions 2004; 13 (Suppl 1): S42-S66. [doi: 10.1080/10550490490440807].
 
35. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
36. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Now That I've Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search